Jae Berm Park

Suggest Changes
Sung Joo Kim60
Choon Hyuck David Kwon52
Jae-Won Joh49
Jong Man Kim39
Suk-Koo Lee28
54Sung Joo Kim
52Choon Hyuck David Kwon
49Jae-Won Joh
43Jong Man Kim
26Suk-Koo Lee

Filter Results:

  • Full text PDF available (26)

Publication Year

2006
2017
  • This year (14)
  • Last 5 years (64)
  • Last 10 years (77)

Publication Type

Co-author

Journals and Conferences

Key Phrases

Learn More
Single-center experience of laparoscopic left pancreatic resection in 359 consecutive patients: changing the surgical paradigm of left pancreatic resection
Laparoscopic distal pancreatectomy (LDP) is increasingly performed for lesions of the body and tail of the pancreas. We analyzed the clinical characteristics of the largest series of patients to date who underwent LDP at a single center, as well as their outcomes, to reassess the surgical paradigm for left pancreatic resection. We retrospectively reviewed… (More)
Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients.
The principal objective of this study was to evaluate the feasibility of Hepatitis B virus (HBV) vaccine switch program after 1-year Hepatitis B immunoglobulin (HBIG) for the prevention of de novo HBV (DNHBV) infection in pediatric recipients of hepatitis B core antibody (anti-HBc)-positive grafts. In this study, we enrolled pediatric recipients (n = 14),… (More)
Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study
Mesenchymal stem cells (MSCs) are multi-potent non-hematopoietic progenitor cells possessing an immune-regulatory function, with suppression of proliferation of activated lymphocytes. In this study, adult living donor kidney transplantation (LDKT) recipients were given MSCs derived from the donor bone marrow to evaluate the safety and the feasibility of… (More)
Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter.
Massive intraoperative bleeding during liver transplantation often requires large amounts of blood products. The goal of this study was to investigate long-term outcomes of living donor liver transplantation (LDLT) recipients with hepatocellular carcinoma (HCC) who underwent intraoperative use of intraoperative blood salvage (IBS) and leukocyte depletion… (More)
Surgical outcomes of pancreatic arteriovenous malformation in a single center and review of literature.
OBJECTIVE Pancreatic arteriovenous malformation (P-AVM) is an extremely rare condition that can be accompanied by fatal complications. We have attempted to identify the possible management guidelines based on our and others' clinical experience. METHODS We retrospectively analyzed our findings including clinical characteristics, imaging modalities, and… (More)
Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
BACKGROUNDS AND OBJECTIVE There is controversy regarding liver function of non-B, non-C hepatocellular carcinoma (NBNC-HCC) patients, the biological behavior of their tumors, and the outcome after surgical treatment. The aims of the present study were to compare clinicopathologic data and long-term clinical outcomes between NBNC-HCC patients and hepatitis B… (More)
The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation
Slow graft function (SGF) can influence overall prognosis in patients receiving deceased donor kidney transplantation (DKT). However, the impact of SGF on renal function remains uncertain. We investigated retrospectively renal function in cases with SGF compared with early graft function (EGF) and delayed graft function (DGF). Renal function after… (More)
HCC in living donor liver transplantation: can we expand the Milan criteria?
BACKGROUND The tumor biology of hepatocellular carcinoma (HCC) affects recurrence after liver transplantation (LT), but most selection guidelines are based only on tumor size and number. The aim of the study is to evaluate the possibility of expanding the selection criteria in living donor LT (LDLT) without compromising patient survival by adding… (More)
Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe.
The problem of graft size is one of the critical factors limiting the expansion of adult-to-adult living donor liver transplantation (LDLT). We compared the outcome of LDLT recipients who received grafts with a graft-to-recipient weight ratio (GRWR) < 0.8% or a GRWR > or = 0.8%, and we analyzed the risk factors affecting graft survival after small-for-size… (More)
C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion
BACKGROUND Hepatocellular carcinoma (HCC) has a high predilection for portal vein invasion, and the prognosis of HCC with malignant portal vein invasion is extremely poor. The objective of this study was to investigate the outcomes and the prognostic factor of recurrence in HCC patients with malignant portal vein invasion. METHODS We retrospectively… (More)